Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations

被引:15
|
作者
McGuire, TR [1 ]
Bociek, GR
Pavletic, SZ
Hock, L
Lynch, J
Schneider, J
Hoie, EB
Tarantolo, S
Haire, WD
机构
[1] Univ Nebraska, Med Ctr 986045, Dept Pharm Practice, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Hematol & Oncol, Omaha, NE 68198 USA
[3] Univ Nebraska, Med Ctr, Dept Prevent & Societal Med, Omaha, NE 68198 USA
关键词
cytokinemia; organ dysfunction after SCT;
D O I
10.1038/sj.bmt.1703238
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Patients receiving high-dose preparation for stem cell transplantation are at risk for organ dysfunction (OD). Signs of early OD include hypoxia, mental status changes, and liver dysfunction. These early signs have not been correlated with potential cytokine mediators. We compared plasma concentrations of IL-6, TNF-alpha, and IL-10 in OD patients and controls. Cytokines were measured before preparation, 5 days before OD, day of OD, and 5 days after OD. TNF-alpha and IL-10 were not measurable prior to preparation. IL-10 was more likely to be measurable in OD patients than in controls 5 days prior to onset of OD (P = 0.039), on the day of OD (P = 0.023), and 5 days later (P < 0.0001). TNF-alpha was more likely to be measurable only on the day of OD (P = 0.0035). IL-6 was significantly elevated in OD patients at all time points. Patients who had measurable IL-6 on admission were 5.1 times more likely to develop OD (95% CI = 1.4-17.9; P = 0.011). Five days prior to OD for each 100 pg/ml increase in IL-6, patients were 2.75 times more likely to develop OD (95% CI = 1.3-5.8; P = 0.0087). The early elevation of IL-6 in patients who develop OD may help identify a high risk group where preventive therapies can be evaluated.
引用
收藏
页码:889 / 893
页数:5
相关论文
共 50 条
  • [1] Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations
    TR McGuire
    GR Bociek
    SZ Pavletic
    L Hock
    J Lynch
    J Schneider
    EB Hoie
    S Tarantolo
    WD Haire
    Bone Marrow Transplantation, 2001, 28 : 889 - 893
  • [2] The relationship of serum cytokine levels to acute GVHD following hematopoietic stem cell transplantation
    Visentainer, JEL
    Lieber, LR
    Persoli, LBL
    Favarelli, MHC
    Vigorito, AC
    Aranha, FJP
    Eid, KAB
    Oliveira, GB
    Miranda, ECM
    De Souza, CA
    BONE MARROW TRANSPLANTATION, 2003, 31 : S107 - S107
  • [3] Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation
    Haire, WD
    CRITICAL CARE MEDICINE, 2002, 30 (05) : S257 - S262
  • [4] IMPACT probability of poor outcome and plasma cytokine concentrations are associated with multiple organ dysfunction syndrome following traumatic brain injury
    Lee, Sungho
    Hwang, Hyunsoo
    Yamal, Jose-Miguel
    Goodman, J. Clay
    Aisiku, Imoigele P.
    Gopinath, Shankar
    Robertson, Claudia S.
    JOURNAL OF NEUROSURGERY, 2019, 131 (06) : 1931 - 1937
  • [5] Relationship between plasma concentrations of cytokine modulators and multiple organ failure in acute pancreatitis
    Ogawa, M
    Hirota, M
    Nozawa, F
    Okabe, A
    Shibata, M
    Kuwata, K
    5TH WORLD CONGRESS ON TRAUMA, SHOCK, INFLAMMATION AND SEPSIS: PATHOPHYSIOLOGY, IMMUNE CONSEQUENCES AND THERAPY, 2000, : 575 - 578
  • [6] HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOLLOWING SOLID-ORGAN TRANSPLANTATION IN CHILDREN
    Riesco, S.
    Gonzalez Martinez, B.
    Rubio, P. M.
    Bueno, D.
    Corral, D.
    Alonso, T.
    Sastre, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S490 - S491
  • [7] Hematopoietic stem-cell transplantation following solid-organ transplantation in children
    Schechter, T.
    Gassas, A.
    Weitzman, S.
    Grant, D.
    Pollock-BarZiv, S.
    Dipchand, A.
    Alexander, S.
    Ali, M.
    Avitzur, Y.
    Doyle, J.
    BONE MARROW TRANSPLANTATION, 2011, 46 (10) : 1321 - 1325
  • [8] Hematopoietic stem-cell transplantation following solid-organ transplantation in children
    T Schechter-Finkelstein
    A Gassas
    S Weitzman
    D Grant
    S Pollock-BarZiv
    A Dipchand
    S Alexander
    M Ali
    Y Avitzur
    J Doyle
    Bone Marrow Transplantation, 2011, 46 : 1321 - 1325
  • [9] Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction
    Kikuta, A.
    Ito, M.
    Mochizuki, K.
    Akaihata, M.
    Nemoto, K.
    Sano, H.
    Ohto, H.
    BONE MARROW TRANSPLANTATION, 2006, 38 (10) : 665 - 669
  • [10] Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction
    A Kikuta
    M Ito
    K Mochizuki
    M Akaihata
    K Nemoto
    H Sano
    H Ohto
    Bone Marrow Transplantation, 2006, 38 : 665 - 669